Boston Scientific Corporation is paying to resolve remaining pelvic mesh lawsuits in 47 states plus the District of Columbia, bringing long-running product safety litigation closer to a final resolution.
Boston Scientific Pays $189M To Resolve Pelvic Mesh Cases
The settlement puts to rest product liability and patient safety suits in 47 states and the District of Columbia.
More from Legal & IP
• By
Energy and Commerce Health Subcommittee Democrats focus on criticizing HHS Secretary Kennedy’s RIF announcement, including 3,500 FDA jobs among cuts across HHS agencies. Representatives were left wondering if user fee programs would continue, even if reauthorized.
• By
A federal judge in Texas delivered what is most likely a fatal blow to the US FDA’s final rule, which would have regulated lab-developed tests as medical devices.
• By
A planned merger between medical device coating manufacturers Surmodics and Biocoat is facing an antitrust lawsuit from the US Federal Trade Commission. The FTC believes the move would create an illegal monopoly.
• By
An attorney representing the ACLA in its lawsuit to stop the US FDA’s final rule on LDTs emerged from a lengthy hearing on the case feeling ‘cautiously optimistic’ and said a decision could come before May.